Yosuke Onishi

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 668 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +4

Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis

Akiyuki Uzawa, Shigeaki Suzuki, Satoshi Kuwabara et al. · Journal of Neurology Neurosurgery & Psychiatry · 2023 · 49 citations

Medicine, Pharmacology, Pharmacotherapy +13

High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis

Akiyuki Uzawa, Hiroyuki Akamine, Yuta Kojima et al. · Journal of Neuroimmunology · 2021 · 39 citations

Life Sciences, Immunology, Autoimmunity +7

Rate of change in acetylcholine receptor antibody levels predicts myasthenia gravis outcome

Yuta Kojima, Akiyuki Uzawa, Yukiko Ozawa et al. · Journal of Neurology Neurosurgery & Psychiatry · 2021 · 37 citations

Life Sciences, Immunology, Internal Medicine +11

Japan <scp>MG</scp> registry: Chronological surveys over 10 years

Shigeaki Suzuki, Masayuki Masuda, Akiyuki Uzawa et al. · Clinical and Experimental Neuroimmunology · 2022 · 35 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10